Clearmind Medicine's Psychedelic Treatment Bags Divisional Patent Approval in China

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY) ("Clearmind" or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced that it has been granted divisional patent approval by the China National Intellectual Property Administration.